Gelonghui, April 23 | Zhifei Biotech (300122.SZ) jumped low and plummeted 12.8% to 35.06 yuan at the beginning of the session. The stock price hit a new low since January 2020. According to the financial report released by Zhifei Biotech last night, revenue in 2023 was 52,918 billion yuan, up 38.30% year on year; net profit attributable to shareholders of listed companies was 8.070 billion yuan, up 7.04% year on year; and non-net profit attributable to shareholders of listed companies was 7.915 billion yuan, up 5.40% year on year. Among them, in the fourth quarter of 2023, the main revenue for the single quarter was 13.646 billion yuan, up 30.7% year on year; net profit from the single quarter was 1.54 billion yuan, down 20.31% year on year; and the single quarter deducted non-net profit of 1,535 billion yuan, down 20.03% year on year.
A股异动丨智飞生物大跌近13%创逾4年新低，Q4净利同比下降20.31%
A-share changes丨Zhifei Biotech plummeted nearly 13% to a new low of more than 4 years, and Q4 net profit fell 20.31% year on year
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.